CT
Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
NASDAQ·Healthcare·Biotechnology
$12.58
-3.05%
Mkt Cap $463.34M
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (8 analysts)
$17.50
Range $14.00 – $22.00
Implied Upside
+39.2%
Consensus $17.50 vs current $12.58